跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TEVA-DILTIAZEM XC - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TEVA-DILTIAZEM XC
Authorized
STANDARD
TEVA-DILTIAZEM XC
TEVA CANADA LIMITED
🇨🇦 Health Canada
Approval Date
Apr 6, 2026
Approval ID
e134ef830808fda3
Company
TEVA CANADA LIMITED
Type
Standard
Approval Details
Approval Id
e134ef830808fda3
Drug Approval Canada Name
TEVA-DILTIAZEM XC
Product Name
TEVA-DILTIAZEM XC
Status
Marketed
Status Date
2022-06-27
Original Market Date
2022-06-27
Drug Class
Human
Dosage Form
Tablet (Extended-Release)
Route Of Administration
Oral
Schedule
PRESCRIPTION
Ahfs
24:28.92
Atc Original
C08DB01 DILTIAZEM
Aig Number
0115863009
Company Name
TEVA CANADA LIMITED
Company Address
30 Novopharm Court Toronto Ontario Canada M1B 2K9
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Apr 6, 2026
Approval ID
e134ef830808fda3
Type
Standard
Back to Health Canada Approvals